ReviewFrontiers in immunology2022

Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.

Mahdi Eskandarian Boroujeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.